Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma ...

A popular theory frequently utilized by technical analysts suggests U.S. stocks could be headed for one last leg higher over ...

The stock market isn’t the economy” is a well-worn adage, but economists at Oxford Economics say moves in equities and other ...

A bear market in AI stocks leads to more attractive valuations. A wide swath of stocks associated with artificial ...

U.S. stock futures are mixed as investors weigh President Donald Trump's announcement of 25% tariffs on all imported ...

Deere's stock hits record highs amid uncertain demand rebound. Learn why mounting risks and limited upside call for cautious ...

Think Long-Term: The market's short-term "moods" are noisy. Focus on fundamentals and time horizons.

Yasuyuki Kuribayashi, Yuko Toyoda, and Kazuki Mochizuki of City-Yuwa Partners provide a guide to the sustainability-related ...

"In 2024, Kenmare delivered EBITDA of $157 million, supporting our ability to fund our capital programme and continue to make shareholder distributions. As such, the Board is proposing a full year ...

Alabama officials are working to navigate the sweeping changes the Trump administration is making to the federal government’s ...

The National Institutes of Health awarded more than $380 million to Alabama researchers in fiscal 2024, which led to $916 ...

Cleantech stock with hydrogen potential! dynaCERT Inc. (ISIN: CA26780A1084 | TSX: DYA) is the focus of analyst Matthias ...